Polycystic Ovary Syndrome and Cardiovascular Disease
Kitapta bölümler > Diğer · 2012
Yazarlar: Bar nder, Derun Taner, Hamiyet Ylmaz, M. Muzaffer
Polycystic Ovary Syndrome, Diğer, Uluslararası, 2012, ,
DOI: 10.5772/25519
Özet
Young women have an inferior risk of cardiac events, but this benefit fades after menopause, leaving them at risk to develop a cardiovascular disease (CVD) (StrambaBadiale, Fox et al. 2006). Endocrine and gynecologic diseases may have impact on this pattern. Ever since the classical notice of Stein and Leventhal in 1935 (Stein and Leventhal. 1935), interest in polycystic ovaries (PCO) and its accompanying syndrome (PCOS) has grown from a ‘‘gynecological curiosity to a multisystem endocrinopathy’’ (Homburg 1996). Actually, polycystic ovary syndrome (PCOS), is the most common female endocrinopathy in up to 10% in reproductive age and appears to be related with an increased cardiovascular risk (Talbott, Guzick et al. 1995; Cibula, Cifkova et al. 2000). The syndrome is characterized by chronic anovulation and hyperandrogenism (Franks 1995; Scarpitta and Sinagra 2000). Cardiovascular disease and type 2 diabetes are two potential major long-term sequelae of this condition that is worth of examination.